Results 211 to 220 of about 1,023,792 (288)

Engaging Broader Stakeholders to Accelerate Group A <i>Streptococcus</i> Vaccine Development. [PDF]

Vaccines (Basel)
Kong D, Pan H, Wu H, Chen J.
europepmc   +1 more source

Interaction of meningococcal conjugate vaccines with other conjugate or diphtheria-tetanus containing vaccines

Journal of Travel Medicine, 2018
Robert Booy, Robert Booy, Mohamad Tashani, Mohamad Tashani, Al-Mamoon Badahdah, Al-Mamoon Badahdah, Al-Mamoon Badahdah, Ameneh Khatami, Harunor Rashid, Harunor Rashid   +9 more
openaire   +2 more sources

Engineered Hydrogels Revolutionize Locoregional Cancer Immunotherapy

Advanced NanoBiomed Research, EarlyView.
This review systematically summarizes the latest research progress on injectable hydrogels in cancer immunotherapy, highlighting their unique advantages in precise immune activation, local drug‐controlled release, and immune microenvironment remodeling. These features provide innovative solutions to overcome the bottlenecks of systemic side effects and
Jiyong Wei, Chunliu Huang, Zenghua Zhou, Yanni Lan   +3 more
wiley   +1 more source

PCV20 for the prevention of invasive pneumococcal disease in the Mexican pediatric population: A cost-effectiveness analysis. [PDF]

Hum Vaccin Immunother
Huerta JL, Ta A, Vinand E, Torres GI, Wannaadisai W, Huang L.   +5 more
europepmc   +1 more source

Nanoparticles Functionalized with Polymer Brushes for Gene Delivery

Advanced NanoBiomed Research, EarlyView.
The engineering of the next generation gene delivery vectors requires the precise control of the architecture and physicochemical interactions controlling the transport, targeting, uptake, and release of nucleic acid materials to targeted cells. Polymer brush‐functionalized nanomaterials offer unprecedented control over such design and properties, and ...
Carlos E. Neri‐Cruz, Julien E. Gautrot
wiley   +1 more source

Development of invasive non-typhoidal Salmonella conjugate vaccines and their evaluation in a trivalent formulation with typhoid conjugate vaccine. [PDF]

Vaccine
An SJ, Yang JS, Chae MH, Woo JS, Kang YE, Ganapathy R, Pansuriya RK, Choi JA, Yoon YK, Lee E, Lee SB, Pandey G, Lee JW, Lee JS, Bae SH, Kweon SW, Kim SJ, Seon SH, Kim JH, Song M.   +19 more
europepmc   +1 more source

Co-delivery of antigen and adjuvant by site-specific conjugation to dendritic cell-targeted Fab fragments potentiates T cell responses. [PDF]

RSC Chem Biol
Wijfjes Z, Ramos Tomillero I, Le Gall CM, van Dinther EAW, Turlings F, Classens R, Manna S, van Dalen D, Peters RJRW, Schouren K, Fennemann FL, Hagemans IM, van Dalen FJ, van der Schoot JMS, Figdor CG, Esser-Kahn A, Scheeren FA, Verdoes M.   +17 more
europepmc   +1 more source

A dynamic transmission model for assessing the impact of pneumococcal vaccination in the United States. [PDF]

PLoS One
Malik TM, Bakker KM, Oidtman RJ, Sharomi O, Meleleo G, Nachbar RB, Elbasha EH.   +6 more
europepmc   +1 more source

Integrated Chemoenzymatic Synthesis of the mRNA Vaccine Building Block N1‐Methylpseudouridine Triphosphate

Angewandte Chemie International Edition, EarlyView.
Pseudouridine‐5′‐triphosphate (ΨTP) and its N1‐methylated derivative (m1ΨTP) are crucial components in mRNA vaccine technology. Here, an atom‐economic, high‐yielding biocatalytic route for ΨTP synthesis is presented. A new chemoenzymatic route for m1ΨTP synthesis was developed.
Martin Pfeiffer, Leo Krammer, Johannes Zöhrer, Rolf Breinbauer, Bernd Nidetzky   +4 more
wiley   +1 more source

Emergence of Azithromycin-resistant Salmonella Typhi in Southeast Asia: A systematic review. [PDF]

Pak J Med Sci
Zaffar S, Sadiqa A.
europepmc   +1 more source